2017
DOI: 10.21037/acs.2017.07.09
|View full text |Cite
|
Sign up to set email alerts
|

Hypertrophic obstructive cardiomyopathy—the Leipzig experience

Abstract: Background: Management of hypertrophic obstructive cardiomyopathy (HOCM) has evolved considerably over the last fifty years, and includes medical treatment as well as septal myectomy (SM) to relief symptoms caused by left ventricular outflow tract obstruction (LVOTO). We report the Leipzig Heart Center experience in the surgical management of patients with HOCM. Methods:We collected data from all patient treated surgically with a myectomy for LVOTO in patients with HOCM between 1997 and 2016. Patients with abs… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(2 citation statements)
references
References 30 publications
0
1
0
1
Order By: Relevance
“…Изолированной МЭ зачастую недостаточно для полного устранения обструкции ВТЛЖ из-за сохраняющегося переднего систолического движения МК за счет изменения Результаты хирургического лечения ГКМП [33][34][35][36][37][38] Results of surgical treatment of HCM [33][34][35][36][37][38] Автор, клиника…”
Section: хирургическое лечениеunclassified
“…Изолированной МЭ зачастую недостаточно для полного устранения обструкции ВТЛЖ из-за сохраняющегося переднего систолического движения МК за счет изменения Результаты хирургического лечения ГКМП [33][34][35][36][37][38] Results of surgical treatment of HCM [33][34][35][36][37][38] Автор, клиника…”
Section: хирургическое лечениеunclassified
“…For patients refractory to medical management, invasive septal reduction therapy that mechanically reduces septal obstruction may be an alternative to ameliorate symptoms, although its impact on quality of life has not been formally assessed. [7][8][9] Thus, there is an unmet need for safe, effective, and disease-specific noninvasive therapy for oHCM to improve quality of life and health status.…”
Section: Introductionmentioning
confidence: 99%